Imeglimin(EMD-387008) is the first in a new tetrahydrotriazine-containing class of oral antidiabetic agents, the glimins; It has been shown to act on the liver, muscle and pancreatic -cells to uniquely target the key defects of type 2 diabetes.
For research use only. We do not sell to patients.
Name | Imeglimin |
---|---|
Iupac Chemical Name | 1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI) |
Synonyms | EMD 387008; EMD387008; EMD-387008 |
Molecular Formula | C6H13N5 |
Molecular Weight | 155.2 |
Smile | C[C@@H]1NC(=N)N=C(N1)N(C)C |
InChiKey | GFICWFZTBXUVIG-SCSAIBSYSA-N |
InChi | InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1 |
CAS Number | 775351-65-0 |
MDL | MFCD19443705 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | crystalline solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |